ArticleJournal of thoracic disease2018
Unidirectional endobronchial valves for management of persistent air-leaks: results of a multicenter study.
Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 64 citations in OpenAlex.
- Endobronchial valves for severe air leak in critically ill children with necrotizing pneumonia requiring extracorporeal membrane oxygenation.Perfusion · 2026Article
- Transforming pulmonary care with applications of endobronchial valves beyond emphysema: a narrative review.Annals of translational medicine · 2025Review
- Endobronchial valve placement for persistent air leaks in patients with underlying lung disease: a case series from a resource-strapped county hospital.Journal of thoracic disease · 2025Article
- Thoracoscopic Closure of Alveolar Pleural Fistula by Application of Pleural Flap and Polymeric Sealant.Thoracic cancer · 2025Article
- Article
- Phrenic nerve infiltration: A good practice to combine pulmonary expansion and pain control in patients with high risk of prolonged air leak.JTCVS open · 2025Article
- A novel case of simultaneous tracheal stenting and endobronchial valve (EBV) deployment for tracheal stenosis and persistent air leak guided by an endobronchial collateral ventilation assessment system and digital chest drain in malignant esophageal carcinoma.Respirology case reports · 2024Article
- Endobronchial valves for emphysema and persistent air-leak: 10-year experience in an Asian country.BMC pulmonary medicine · 2024Article
- One-way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient.Thoracic cancer · 2023Article
- Bronchoscopic Endobronchial Valve Therapy for Persistent Air Leaks in COVID-19 Patients Requiring Veno-Venous Extracorporeal Membrane Oxygenation.Journal of clinical medicine · 2023Article
- Single-Use and Reusable Flexible Bronchoscopes in Pulmonary and Critical Care Medicine.Diagnostics (Basel, Switzerland) · 2022Review
- Successful use of endobronchial valve for persistent air leak in a patient with COVID-19 and bullous emphysema.BMJ case reports · 2021Article
- Short and long-term outcomes of surgical intervention for empyema in the post-fibrinolytic era.Journal of cardiothoracic surgery · 2021Article
- Modified silicone stent for the treatment of post-surgical bronchopleural fistula: a clinical observation of 17 cases.BMC pulmonary medicine · 2021Article
- Tracheal fistula repair with stent placement after failure of reconstruction with muscle tissue. A lung cancer surgery complication.Respiratory medicine case reports · 2021Article
- One-Way Endobronchial Valves as Management for Persistent Air Leaks: A Preview of What's to Come?American journal of respiratory and critical care medicine · 2019Article
- Article
- Combined intrapleural and intrabronchial injection of fibrin glue for closing alveolar pleural fistula: a case report.Journal of cardiothoracic surgery · 2019Article
- Management of air leaks post-surgical lung resection.Annals of translational medicine · 2019Review
- Tailored airway stent: the new frontiers of the endoscopic treatment of broncho-pleural fistula.Journal of thoracic disease · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the efficacy of Endo-Bronchial Valves in the management of persistent air-leaks (PALs) and the procedural cost.
methodsIt was a retrospective multicenter study including consecutive patients with PALs for alveolar pleural fistula (APF) undergoing valve treatment. We assessed the efficacy and the cost of the procedure.
resultsSeventy-four patients with persistent air leaks due to various etiologies were included in the analysis. In all cases the air leaks were severe and refractory to standard treatments. Sixty-seven (91%) patients underwent valve treatment obtaining a complete resolution of air-leaks in 59 (88%) patients; a reduction of air-leaks in 6 (9%); and no benefits in 2 (3%). The comparison of data before and after valve treatment showed a significant reduction of air-leak duration (16.2±8.8 versus 5.0±1.7 days; P<0.0001); chest tube removal (16.2±8.8 versus 7.3±2.7 days; P<0.0001); and length of hospital stay (LOS) (16.2±8.8 versus 9.7±2.8 days; P=0.004). Seven patients not undergoing valve treatment underwent pneumo-peritoneum with pleurodesis (n=6) or only pleurodesis (n=1). In only 1 (14%) patient, the chest drainage was removed 23 days later while the remaining 6 (86%) were discharged with a domiciliary chest drainage removed after 157±41 days. No significant difference was found in health cost before and after endobronchial valve (EBV) implant (P=0.3).
conclusionsValve treatment for persistent air leaks is an effective procedure. The reduction of hospitalization costs related to early resolution of air-leaks could overcome the procedural cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.